Xiaowei Deng

2.9k total citations · 2 hit papers
38 papers, 944 citations indexed

About

Xiaowei Deng is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Xiaowei Deng has authored 38 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Modeling and Simulation and 10 papers in Epidemiology. Recurrent topics in Xiaowei Deng's work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 epidemiological studies (11 papers) and COVID-19 Clinical Research Studies (7 papers). Xiaowei Deng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 epidemiological studies (11 papers) and COVID-19 Clinical Research Studies (7 papers). Xiaowei Deng collaborates with scholars based in China, United States and United Kingdom. Xiaowei Deng's co-authors include Hongjie Yu, Juan Yang, Wanying Lu, Qianhui Wu, Marco Ajelli, Zeyao Zhao, Xinhua Chen, Zhiyuan Chen, Ruijia Sun and Cécile Viboud and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Xiaowei Deng

33 papers receiving 930 citations

Hit Papers

Modeling transmission of SARS-CoV-2 Omicron in China 2021 2026 2022 2024 2022 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Modeling transmission of SARS-CoV-2 Omicron in China
    2022 175 citations Jun Cai, Xiaowei Deng et al. Nature Medicine profile →
  2. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials
    2021 173 citations Gang Zeng, Qianhui Wu et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Deng China 13 599 320 180 127 65 38 944
Young-Joon Park South Korea 18 387 0.6× 136 0.4× 139 0.8× 161 1.3× 89 1.4× 79 1.0k
Ruijia Sun China 9 446 0.7× 217 0.7× 98 0.5× 73 0.6× 68 1.0× 12 620
Timothy B. Frankland United States 12 899 1.5× 237 0.7× 427 2.4× 192 1.5× 69 1.1× 36 1.2k
Hira Imeri Switzerland 6 453 0.8× 332 1.0× 41 0.2× 94 0.7× 35 0.5× 7 710
Pragati Prasad United States 7 447 0.7× 261 0.8× 62 0.3× 136 1.1× 24 0.4× 9 698
Talía M. Quandelacy United States 8 471 0.8× 308 1.0× 73 0.4× 189 1.5× 30 0.5× 18 816
Anusha Sultan Meo Saudi Arabia 11 427 0.7× 106 0.3× 131 0.7× 63 0.5× 124 1.9× 31 878
Alessio Andronico France 12 528 0.9× 468 1.5× 93 0.5× 169 1.3× 41 0.6× 18 939
Wycliffe Enli Wei Singapore 7 534 0.9× 325 1.0× 75 0.4× 78 0.6× 38 0.6× 10 939
Molly Steele United States 11 566 0.9× 324 1.0× 109 0.6× 130 1.0× 29 0.4× 19 926

Countries citing papers authored by Xiaowei Deng

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Deng more than expected).

Fields of papers citing papers by Xiaowei Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Deng. The network helps show where Xiaowei Deng may publish in the future.

Co-authorship network of co-authors of Xiaowei Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Deng. A scholar is included among the top collaborators of Xiaowei Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Deng. Xiaowei Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xiaowei, et al.. (2025). Preparation of ultra-low ash coal from nonstick coal by using high-speed shear selective-agglomeration flotation. International Journal of Coal Preparation and Utilization. 46(3). 848–864.
2.
Fang, Chaojun, et al.. (2025). Critical metal recovery from red mud: A systematic review of sustainable extraction technologies and circular economy potential. Journal of environmental chemical engineering. 13(5). 118985–118985. 1 indexed citations
3.
4.
Deng, Xiaowei. (2025). Live Streams Effect on Generation Z's Impulsive Shopping Behavior. Advances in Economics Management and Political Sciences. 154(1). 167–172.
5.
6.
Tsui, Joseph L.-H., Bernardo Gutiérrez, Louis du Plessis, et al.. (2024). COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses. Science. 386(6722). eadq3003–eadq3003. 34 indexed citations
7.
8.
Cai, Jun, Xiaowei Deng, Juan Yang, et al.. (2022). Modeling transmission of SARS-CoV-2 Omicron in China. Nature Medicine. 28(7). 1468–1475. 175 indexed citations breakdown →
9.
Liu, Hengcong, Juanjuan Zhang, Jun Cai, et al.. (2022). Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. BMC Medicine. 20(1). 37–37. 12 indexed citations
10.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis. Clinical Infectious Diseases. 74(4). 734–742. 67 indexed citations
11.
Yang, Juan, Valentina Marziano, Xiaowei Deng, et al.. (2021). Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. Nature Human Behaviour. 5(8). 1009–1020. 65 indexed citations
12.
Zeng, Gang, Qianhui Wu, Hongxing Pan, et al.. (2021). Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. The Lancet Infectious Diseases. 22(4). 483–495. 173 indexed citations breakdown →
13.
Chen, Xinhua, Zhiyuan Chen, Andrew S. Azman, et al.. (2021). Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. The Lancet Global Health. 9(5). e598–e609. 126 indexed citations
14.
Yang, Juan, Hui Gong, Xinhua Chen, et al.. (2020). Health‐seeking behaviors of patients with acute respiratory infections during the outbreak of novel coronavirus disease 2019 in Wuhan, China. Influenza and Other Respiratory Viruses. 15(2). 188–194. 13 indexed citations
15.
Zhang, Wei, et al.. (2020). Association of the IL-1B rs1143623 Polymorphism and Cancer Risk: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 24(10). 685–688. 1 indexed citations
16.
Chen, Junbo, Huachen Zhu, Peter Horby, et al.. (2020). Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans. Journal of Infection. 80(3). 310–319. 11 indexed citations
17.
Yang, Juan, Xinhua Chen, Xiaowei Deng, et al.. (2020). Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China. Nature Communications. 11(1). 5411–5411. 66 indexed citations
18.
Er, Yuliang, et al.. (2019). [Disease burden on falls among 0-19 years old population in China, in 1990 and 2017].. PubMed. 40(11). 1363–1368. 3 indexed citations
19.
Dong, Yanan, Jiageng Chen, Xiyue Jing, et al.. (2019). Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment. BMJ Open. 9(6). e024807–e024807. 6 indexed citations
20.
Liu, Li, et al.. (2018). A retrospective study of traditional Chinese medicine as an adjunctive therapy for patients with chronic heart failure. Medicine. 97(30). e11696–e11696. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young-Joon Park Breakdown of academic impact, for papers by Ruijia Sun Breakdown of academic impact, for papers by Timothy B. Frankland Breakdown of academic impact, for papers by Hira Imeri Breakdown of academic impact, for papers by Pragati Prasad Breakdown of academic impact, for papers by Talía M. Quandelacy Breakdown of academic impact, for papers by Anusha Sultan Meo Breakdown of academic impact, for papers by Alessio Andronico Breakdown of academic impact, for papers by Wycliffe Enli Wei Breakdown of academic impact, for papers by Molly Steele
Rankless by CCL
2026